Evidence map›Paper›PMID 24994823›Full record

ArticleAJNR. American journal of neuroradiology

WEB intrasaccular flow disruptor-prospective, multicenter experience in 83 patients with 85 aneurysms.

C Papagiannaki, L Spelle, A-C Januel, A Benaissa, J-Y Gauvrit, V Costalat, H Desal, F Turjman, S Velasco, X Barreau and 5 more

Abstract readMulticenter Study
In one paragraph

Article in AJNR. American journal of neuroradiology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 64 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
64citing papers in PubMed, 7 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

64 citing papers in PubMed, 7 syntheses or guidelines pooled it.

  1. The Woven EndoBridge device, an effective and safe alternative endovascular treatment of intracranial aneurysm-systematic review.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2026
    Pooled it
  2. Pooled it
  3. Pooled it
  4. Woven EndoBridge device for the treatment of ruptured intracranial aneurysms: A systematic review of clinical and angiographic results.Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2022
    Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Trial
  15. Article
  16. Article
  17. Observational
  18. The impact of pre-treatment aneurysm angulation. What happens with WEB devices at follow-up?Interventional neuroradiology : journal of peritherapeutic neuroradiology, surgical procedures and related neurosciences · 2025
    Article
  19. Observational
  20. Article

4 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

15 authors.

C PapagiannakiFrom the Department of Neuroradiology (C.P., D.H.), Centre Hospitalier Universitaire (CHU) Tours, Tours, France.
L SpelleDepartment of Neuroradiology (L.S., J.M.), Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
A-C JanuelDepartment of Neuroradiology (A.-C.J., C.C.), CHU Toulouse, Toulouse, France.
A BenaissaDepartment of Neuroradiology (A.B., L.P.), CHU Reims, Reims, France.
J-Y GauvritDepartment of Neuroradiology (J.-Y.G.), CHU Rennes, Rennes, France.
V CostalatDepartment of Neuroradiology (V.C.), CHU Montpellier, Montpellier, France.
H DesalDepartment of Neuroradiology (H.D.), CHU Nantes, Nantes, France.
F TurjmanDepartment of Neuroradiology (F.T.), CHU Lyon, Lyon France.
S VelascoDepartment of Neuroradiology (S.V.), CHU Poitiers, Poitiers, France.
X BarreauDepartment of Neuroradiology (X.B.), CHU Bordeaux, Bordeaux, France.
P CourtheouxDepartment of Neuroradiology (P.C.), CHU Caen, Caen, France.
C CognardDepartment of Neuroradiology (A.-C.J., C.C.), CHU Toulouse, Toulouse, France.
D HerbreteauFrom the Department of Neuroradiology (C.P., D.H.), Centre Hospitalier Universitaire (CHU) Tours, Tours, France.
J MoretDepartment of Neuroradiology (L.S., J.M.), Hôpital Beaujon, Assistance Publique-Hôpitaux de Paris, Clichy, France.
L PierotDepartment of Neuroradiology (A.B., L.P.), CHU Reims, Reims, France lpierot@gmail.com.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

background and purposeThe safety and efficacy of WEB flow disruption have been analyzed in small, retrospective series. The object of this study was to evaluate the safety and efficacy of WEB flow disruption in a large, multicenter, prospectively collected population. MATERIALS AND

methodsData from all patients treated with the WEB-DL device between June 2011 and October 2013 in 11 French neurointerventional centers were prospectively collected and retrospectively analyzed. Complications occurring during and after treatment were analyzed as well as morbidity and mortality at 1 month. Aneurysm occlusion status at the last follow-up was analyzed.

resultsEighty-three patients with 85 aneurysms were included in this series. Technical success was achieved in 77 patients with 79 aneurysms (92.9%). Periprocedural complications were observed in 9 patients (10.8%), leading to permanent neurologic deficits in 3 (3.9%). Morbidity and mortality at 1 month were 1.3% and 0.0%, respectively. Angiographic follow-up was performed for 65/79 aneurysms (82.3%) 3-24 months after treatment (mean, 5.3 months). Complete aneurysm occlusion was observed in 37/65 aneurysms (56.9%); neck remnant, in 23/65 (35.4%); and aneurysm remnant, in 5/65 (7.7%).

conclusionsIn this large prospective series of patients, WEB flow disruption was a safe and efficient technique.

Indexed as

AdultAgedBlood Vessel ProsthesisEmbolization, TherapeuticEndovascular ProceduresFemaleHumansIntracranial AneurysmMaleMiddle AgedProspective StudiesRetrospective StudiesTreatment Outcome

Identifiers

PMID24994823
PMCPMC7965185

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.